vs
安捷伦科技（A）与Ardent Health, Inc.（ARDT）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Ardent Health, Inc.的1.1倍（$1.8B vs $1.6B）。安捷伦科技净利率更高（17.0% vs 2.8%，领先14.2%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Goodlife Health Clubs是一家健身俱乐部连锁品牌，在澳大利亚拥有超过80家门店，是当地颇具规模的健身服务提供商，为消费者提供专业的健身场地、器械及相关健身体验服务。
A vs ARDT — 直观对比
营收规模更大
A
是对方的1.1倍
$1.6B
净利率更高
A
高出14.2%
2.8%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.6B |
| 净利润 | $305.0M | $45.0M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | 5.8% |
| 净利率 | 17.0% | 2.8% |
| 营收同比 | 7.0% | — |
| 净利润同比 | -4.1% | — |
| 每股收益（稀释后） | $1.07 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AARDT
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.6B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.5B |
净利润AARDT
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $45.0M | ||
| Q3 25 | $336.0M | $-23.5M | ||
| Q2 25 | $215.0M | $73.0M | ||
| Q1 25 | $318.0M | $41.4M | ||
| Q4 24 | $351.0M | — | ||
| Q3 24 | $282.0M | $26.3M | ||
| Q2 24 | $308.0M | $42.8M |
毛利率AARDT
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率AARDT
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 5.8% | ||
| Q3 25 | 20.7% | -0.1% | ||
| Q2 25 | 18.0% | 7.4% | ||
| Q1 25 | 22.4% | 5.0% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | 3.9% | ||
| Q2 24 | 23.1% | 5.6% |
净利率AARDT
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 2.8% | ||
| Q3 25 | 19.3% | -1.5% | ||
| Q2 25 | 12.9% | 4.4% | ||
| Q1 25 | 18.9% | 2.8% | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 17.9% | 1.8% | ||
| Q2 24 | 19.6% | 2.9% |
每股收益（稀释后）AARDT
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.32 | ||
| Q3 25 | $1.18 | $-0.17 | ||
| Q2 25 | $0.75 | $0.52 | ||
| Q1 25 | $1.11 | $0.29 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.97 | $0.19 | ||
| Q2 24 | $1.05 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $709.6M |
| 总债务越低越好 | $3.0B | $1.1B |
| 股东权益账面价值 | $6.9B | $1.3B |
| 总资产 | $12.8B | $5.3B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资AARDT
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $709.6M | ||
| Q3 25 | $1.5B | $609.4M | ||
| Q2 25 | $1.5B | $540.6M | ||
| Q1 25 | $1.5B | $495.0M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | $563.1M | ||
| Q2 24 | $1.7B | $334.5M |
总债务AARDT
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $1.1B | ||
| Q3 25 | $3.4B | $1.1B | ||
| Q2 25 | $3.3B | $1.1B | ||
| Q1 25 | $3.3B | $1.1B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.1B | $1.1B |
股东权益AARDT
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $1.3B | ||
| Q3 25 | $6.4B | $1.2B | ||
| Q2 25 | $6.1B | $1.3B | ||
| Q1 25 | $6.0B | $1.2B | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $5.9B | $1.0B | ||
| Q2 24 | $6.2B | $739.9M |
总资产AARDT
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $5.3B | ||
| Q3 25 | $12.2B | $5.2B | ||
| Q2 25 | $12.2B | $5.0B | ||
| Q1 25 | $11.9B | $4.9B | ||
| Q4 24 | $11.8B | — | ||
| Q3 24 | $11.0B | $4.8B | ||
| Q2 24 | $10.9B | $4.6B |
负债/权益比AARDT
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.84× | ||
| Q3 25 | 0.53× | 0.88× | ||
| Q2 25 | 0.55× | 0.87× | ||
| Q1 25 | 0.56× | 0.93× | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | 1.08× | ||
| Q2 24 | 0.34× | 1.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $223.4M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | — |
| 自由现金流率自由现金流/营收 | 9.7% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.88× | 4.97× |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势，按日历期对齐
经营现金流AARDT
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $223.4M | ||
| Q3 25 | $362.0M | $154.4M | ||
| Q2 25 | $221.0M | $117.5M | ||
| Q1 25 | $431.0M | $-24.8M | ||
| Q4 24 | $481.0M | — | ||
| Q3 24 | $452.0M | $89.7M | ||
| Q2 24 | $333.0M | — |
自由现金流AARDT
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率AARDT
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度AARDT
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率AARDT
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 4.97× | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | 1.61× | ||
| Q1 25 | 1.36× | -0.60× | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 3.41× | ||
| Q2 24 | 1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ARDT
暂无分部数据
